Ionis Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $267,949 | $246,091 | $203,000 | $156,719 |
Gross Profit | 265,210 | 243,108 | 195,000 | 154,381 |
EBITDA | -105,331 | -68,524 | -202,659 | -103,339 |
EBIT | -108,764 | -75,310 | -210,000 | -107,841 |
Net Income | -114,646 | -92,528 | -229,000 | -128,606 |
Net Change In Cash | 267,949 | 246,091 | 203,000 | 156,719 |
Free Cash Flow | 549,451 | -814,582 | -159,001 | -134,743 |
Cash | 350,065 | 173,381 | 372,260 | 338,341 |
Basic Shares | 165,419 | 164,874 | 162,000 | 160,758 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $944,000 | $705,138 | $787,647 | $587,367 |
Gross Profit | 928,000 | 693,923 | 778,514 | 573,251 |
EBITDA | -284,306 | -353,721 | -235,870 | -227,758 |
EBIT | -307,000 | -375,711 | -258,368 | -249,863 |
Net Income | -381,000 | -453,897 | -366,286 | -269,722 |
Net Change In Cash | 944,000 | 705,138 | 787,647 | 587,367 |
Cost of Revenue | -592,301 | |||
Free Cash Flow | -320,027 | -546,227 | -335,524 | -294,469 |
Cash | 372,260 | 242,077 | 399,266 | 276,472 |
Basic Shares | 160,000 | 149,514 | 143,190 | 141,848 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.70 |
2026-03-31 | -$0.30 |
2025-12-31 | -$1.14 |
2025-09-30 | -$0.61 |